Nutreco

Stellapps Technologies Private Limited is an Internet of Things (IoT) company based in Bengaluru, India, focused on enhancing the dairy supply chain. Founded in 2011, Stellapps develops a range of innovative software applications designed to optimize dairy management. Key products include SmartMoo, an automated cow-milking application aimed at reducing waste, and MooOn, a wearable device for monitoring cattle health and herd management. The company also offers smartAMCU, an automatic milk collection unit controlled via an Android IoT device, and smartCC, a cloud-based solution for managing milk chilling centers. Stellapps provides consultancy services in fodder planning, milk collection, distribution, and marketing, utilizing advanced technologies such as big data, cloud computing, and data analytics. By leveraging these technologies, Stellapps aims to improve operational efficiency and profitability for dairy farmers and cooperatives.

Stellapps Technologies Private Limited is an Internet of Things (IoT) company based in Bengaluru, India, focused on enhancing the dairy supply chain. Founded in 2011, Stellapps develops a range of innovative software applications designed to optimize dairy management. Key products include SmartMoo, an automated cow-milking application aimed at reducing waste, and MooOn, a wearable device for monitoring cattle health and herd management. The company also offers smartAMCU, an automatic milk collection unit controlled via an Android IoT device, and smartCC, a cloud-based solution for managing milk chilling centers. Stellapps provides consultancy services in fodder planning, milk collection, distribution, and marketing, utilizing advanced technologies such as big data, cloud computing, and data analytics. By leveraging these technologies, Stellapps aims to improve operational efficiency and profitability for dairy farmers and cooperatives.

Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases. The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

PROTEON uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics. We have developed a platform to develop and deliver bacteriophages for animal health solutions. Our pipeline includes solutions to prophylactically improve performance and food safety in poultry, as well as important prevent economically important bacterial diseases in aquaculture and dairy.

ENOUGH, formerly known as 3fbio Ltd., is a technology spin-out from the University of Strathclyde, established to develop and commercialize innovative patented technology for the production of mycoprotein, a meat-free food product. The company employs integrated fermentation processes that combine the production of mycoprotein with existing bio-refinery operations, which also generate bioethanol and animal feed as co-products. By utilizing glucose syrup as feedstock for mycoprotein and carbohydrate feedstock for bioethanol, ENOUGH aims to enhance production economics while promoting sustainable food solutions. Incorporated in 2015 and based in Glasgow, United Kingdom, the company focuses on transforming the food, fuel, and feed sectors through its advanced production methods.

ViAqua Therapeutics Ltd, founded in 2014 and based in Misgav, Israel, specializes in developing innovative therapeutics for the aquaculture industry. The company focuses on addressing viral epidemics that threaten aquatic species, particularly shrimp. Its flagship product is an orally administered, particle-based platform that employs a proprietary RNAi nanoparticle formulation. This formulation prompts a cellular response to inhibit viral infections and is delivered through feed or immersion methods. By enhancing disease resistance, ViAqua Therapeutics aims to support the aquaculture sector in managing and preventing viral diseases, ultimately contributing to the sustainability and productivity of aquaculture operations.

Mosa Meat B.V., founded in 2013 and based in Maastricht, the Netherlands, specializes in the development of cultured meat through advanced tissue engineering techniques. The company focuses on producing slaughter-free hamburgers by harvesting adult stem cells from the muscle tissue of living cows, allowing for the mass production of meat without the need to raise and slaughter animals. By cultivating meat from cells, Mosa Meat aims to promote a sustainable global food system and reduce the environmental impact associated with traditional meat production.

Mosa Meat B.V., founded in 2013 and based in Maastricht, the Netherlands, specializes in the development of cultured meat through advanced tissue engineering techniques. The company focuses on producing slaughter-free hamburgers by harvesting adult stem cells from the muscle tissue of living cows, allowing for the mass production of meat without the need to raise and slaughter animals. By cultivating meat from cells, Mosa Meat aims to promote a sustainable global food system and reduce the environmental impact associated with traditional meat production.

BlueNalu is a cellular aquaculture company that satisfies the global appetite for seafood in a fresh, sustainable, and humane way. It offers consumers with great tasting, healthy, safe, and trusted seafood products, that support the sustainability and diversity of the oceans. The company was founded in 2017 and is headquartered in San Diego, California.

Mosa Meat B.V., founded in 2013 and based in Maastricht, the Netherlands, specializes in the development of cultured meat through advanced tissue engineering techniques. The company focuses on producing slaughter-free hamburgers by harvesting adult stem cells from the muscle tissue of living cows, allowing for the mass production of meat without the need to raise and slaughter animals. By cultivating meat from cells, Mosa Meat aims to promote a sustainable global food system and reduce the environmental impact associated with traditional meat production.

Macrobio is a local shrimp farm. The company focuses on providing local shrimp production with the most advanced genetics and breeding technologies and nutritional solutions from the aquaculture feed supply.

ViAqua Therapeutics Ltd, founded in 2014 and based in Misgav, Israel, specializes in developing innovative therapeutics for the aquaculture industry. The company focuses on addressing viral epidemics that threaten aquatic species, particularly shrimp. Its flagship product is an orally administered, particle-based platform that employs a proprietary RNAi nanoparticle formulation. This formulation prompts a cellular response to inhibit viral infections and is delivered through feed or immersion methods. By enhancing disease resistance, ViAqua Therapeutics aims to support the aquaculture sector in managing and preventing viral diseases, ultimately contributing to the sustainability and productivity of aquaculture operations.

Eruvaka Technologies Private Limited develops and sells on-farm diagnostic equipment for aquaculture farmers. The company offers Eruvaka Floating Buoy that measures in real time the water parameters that are crucial for shrimp growth and survival. Its equipment is connected to a mobile application, which enables farmers to monitor their pond data from smartphone. The company was incorporated in 2012 and is based in Guntur, India.

Hi-Pro Feeds LP is a manufacturer and distributor of animal nutrition products, operating in Canada and the United States. Founded in 2012 and based in Okotoks, Canada, the company specializes in producing a wide range of feeds designed for various animal species, including dairy and beef cattle, poultry, swine, sheep, goats, and wildlife. Hi-Pro Feeds offers bulk feed, pre-mixes, dietary supplements, and commodity ingredients aimed at optimizing the health and nutrition of livestock. The company serves commercial producers through a network of dealers, ensuring that its products meet the needs of the agricultural sector. As of 2017, Hi-Pro Feeds operates as a subsidiary of Nutreco N.V.